Showing results (661-670 of 673) with videos related to

Sort By:
Pageof 68
Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
The Lancet. Infectious Diseases|November 17, 2022
Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trialOlivier Marcy, Eric Wobudeya, Hélène Font, et al.
The Lancet. Infectious Diseases|March 13, 2016
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisFrancisco M Marty, Luis Ostrosky-Zeichner, Oliver A Cornely, et al.
Msphere|January 20, 2017
The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of CryptococcosisKyung J Kwon-Chung, John E Bennett, Brian L Wickes, et al.
The Lancet. Infectious Diseases|August 22, 2021
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASMSharon C-A Chen, John Perfect, Arnaldo L Colombo, et al.
The Lancet. Infectious Diseases|October 23, 2018
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countriesAngela Loyse, Jessica Burry, Jennifer Cohn, et al.
Cell|May 21, 2021
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodiesWilton B Williams, R Ryan Meyerhoff, R J Edwards, et al.
Plos Genetics|April 19, 2014
Analysis of the genome and transcriptome of Cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuationGuilhem Janbon, Kate L Ormerod, Damien Paulet, et al.
Pageof 68